João Paulo Tavanez

João Paulo Tavanez

Auto-generated profile, based on publicly available information

João Paulo Tavanez

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2012 in RNA
Verified
Journal Article
Closed access
HBHeike Berndt
Heike Berndt
CHChristiane Harnisch
Christiane Harnisch
CRChristiane Rammelt
Christiane Rammelt
NSNadine Stöhr
Nadine Stöhr
AZAnne Zirkel
Anne Zirkel
EWElmar Wahle
Elmar Wahle
Small nucleolar and small Cajal body RNAs (snoRNAs and scaRNAs) of the H/ACA box and C/D box type are generated by exonucleolytic shortening of longer precursors. Removal of the last few nucleotides at the 3′ end is known to be a distinct step. We report that, in human cells, knock-down of the poly(A) specific ribonuclease (PARN), previously implicated only in mRNA metabolism, causes the accumulation of oligoadenylated processing intermediates of H/ACA box but not C/D box RNAs. In agreement with a role of PARN in snoRNA and scaRNA processing, the enzyme is concentrated in nucleoli and Cajal bodies. Oligo(A) tails are attached to a short stub of intron sequence remaining beyond the mature 3′ end of the snoRNAs. The noncanonical poly(A) polymerase PAPD5 is responsible for addition of the oligo(A) tails. We suggest that deadenylation is coupled to clean 3′ end trimming, which might serve to enhance snoRNA stability.

1 February 2012 in Molecular Cell
Verified
Journal Article
Closed access
JTJoao Paulo Tavanez
Joao Paulo Tavanez
TMTobias Madl
Tobias Madl
HKHamed Kooshapur
Hamed Kooshapur
MSMichael Sattler
Michael Sattler
JVJuan Valcárcel
Juan Valcárcel

1 August 2002 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
MLMiguel Lafarga
Miguel Lafarga
MBMaria Teresa Berciano
Maria Teresa Berciano
EPEmma Pena
Emma Pena
IMIsabel Mayo
Isabel Mayo
JCJosé G. Castaño
José G. Castaño
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca
Nuclear bodies represent a heterogeneous class of nuclear structures. Herein, we describe that a subset of nuclear bodies is highly enriched in components of the ubiquitin–proteasome pathway of proteolysis. We coined the term clastosome (from the Greekklastos, broken and soma, body) to refer to this type of nuclear body. Clastosomes contain a high concentration of 1) ubiquitin conjugates, 2) the proteolytically active 20S core and the 19S regulatory complexes of the 26S proteasome, and 3) protein substrates of the proteasome. Although detected in a variety of cell types, clastosomes are scarce under normal conditions; however, they become more abundant when proteasomal activity is stimulated. In contrast, clastosomes disappear when cells are treated with proteasome inhibitors. Protein substrates of the proteasome that are found concentrated in clastosomes include the short-lived transcription factors c-Fos and c-Jun, adenovirus E1A proteins, and the PML protein. We propose that clastosomes are sites where proteolysis of a variety of protein substrates is taking place.

9 December 2002 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ACAlexandre Calapez
Alexandre Calapez
HPHenrique Pereira
Henrique Pereira
ÂCÂngelo Calado
Ângelo Calado
JBJosé Braga
José Braga
JRJosé Rino
José Rino
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca
FAter being released from transcription sites, messenger ribonucleoprotein particles (mRNPs) must reach the nuclear pore complexes in order to be translocated to the cytoplasm. Whether the intranuclear movement of mRNPs results largely from Brownian motion or involves molecular motors remains unknown. Here we have used quantitative photobleaching techniques to monitor the intranuclear mobility of protein components of mRNPs tagged with GFP. The results show that the diffusion coefficients of the poly(A)-binding protein II (PABP2) and the export factor TAP are significantly reduced when these proteins are bound to mRNP complexes, as compared with nonbound proteins. The data further show that the mobility of wild-type PABP2 and TAP, but not of a point mutant variant of PABP2 that fails to bind to RNA, is significantly reduced when cells are ATP depleted or incubated at 22°C. Energy depletion has only minor effects on the intranuclear mobility of a 2,000-kD dextran (which corresponds approximately in size to 40S mRNP particles), suggesting that the reduced mobility of PABP2 and TAP is not caused by a general alteration of the nuclear environment. Taken together, the data suggest that the mobility of mRNPs in the living cell nucleus involves a combination of passive diffusion and ATP-dependent processes.

5 April 2005 in RNA
Verified
Journal Article
Open access
PDF file
JTJoão Paulo Tavanez
João Paulo Tavanez
PCPatricia Calado
Patricia Calado
JBJosé Braga
José Braga
MLMiguel Lafarga
Miguel Lafarga
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca
A broad range of degenerative diseases is associated with intracellular inclusions formed by toxic, aggregation-prone mutant proteins. Intranuclear inclusions constitute a pathological hallmark of oculopharyngeal muscular dystrophy (OPMD), a dominantly inherited disease caused by (GCG) repeat expansions in the gene that encodes for nuclear poly(A) binding protein (PABPN1). The mutation results in an extended polyalanine stretch that has been proposed to induce protein aggregation and formation of intranuclear inclusions. Here we show that normal PABPN1 is inherently aggregation-prone when exogenously expressed in either HeLa or myogenic C2 cells. Similar deposits of insoluble PABPN1 are formed by variant forms of the protein containing either a polyalanine expansion or a complete deletion of the polyalanine tract, indicating that the mutation responsible for OPMD is not essential for formation of PABPN1 inclusions. In contrast, interfering with any of the protein domains required for stimulation of poly(A) polymerase prevents the formation of inclusions. Most surprisingly, photobleaching experiments reveal that both normal and expanded PABPN1 molecules are not irreversibly sequestered into aggregates, but rather move rapidly in and out of the inclusions. These findings have important implications for the interpretation of OPMD model systems based on exogenous expression of PABPN1.

24 April 2002 in RNA
Verified
Journal Article
Closed access
PDF file
JTJoão P. Tavanez
João P. Tavanez
Celso CunhaCelso Cunha
Celso Cunha
MSMaria C.A. Silva
Maria C.A. Silva
EDEzio David
Ezio David
JMJoão Monjardino
João Monjardino
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca
Hepatitis delta virus (HDV) infection of individuals infected with hepatitis B virus (HBV) is associated with more severe liver damage and an increased risk of fulminant disease. HDV is a single-stranded RNA virus that encodes a single protein, the delta antigen, which is expressed in two forms, small (S-HDAg) and large (L-HDAg). Here we show that although HDV ribonucleoproteins are mainly detected in the nucleus, they are also present in the cytoplasm of cells infected with HDV or transfected with HDV cDNA. Making use of an heterokaryon assay, we demonstrate that HDV ribonucleoproteins shuttle continuously between the nucleus and the cytoplasm. In the absence of HDV RNA, both forms of the delta antigen are retained in the nucleus, whereas in the absence of the delta antigen, HDV RNA is predominantly detected in the cytoplasm. Coexpression of HDV RNA and S-HDAg (which binds to the viral RNA and contains a nuclear localization signal) results in nuclear accumulation of the viral RNA. This suggests that HDV RNA mediates export of viral particles to the cytoplasm whereas the delta antigen triggers their reimport into the nucleus.